Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615
This examiner grants 79% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17616439 | ULTRAVIOLET ABSORBER, PREPARATION METHOD THEREFOR, AND ULTRAVIOLET SCREENING PRODUCT CONTAINING SAME | Non-Final OA | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 18711268 | BIOFILM-TARGETING NANOPARTICLES TO INCREASE THE ANTICARIES EFFECT OF FLUORIDE | Non-Final OA | The Regents of The University of Michigan |
| 18245425 | ORAL DRUG DELIVERY DEVICE WITH EXPANDING BAND | Non-Final OA | Eli Lilly and Company |
| 18566778 | A PHOTORESPONSIVE DELIVERY SYSTEM BASED ON A MODIFIED PAMAM AND METHODS THEREOF | Non-Final OA | THE UNIVERSITY OF HONG KONG |
| 18696272 | A Drug Coating Formulation for a Sirolimus Coated Balloon Catheter | Non-Final OA | C. R. Bard, Inc. |
| 18475416 | GUMMY DOSAGE FORMS | Non-Final OA | Kenvue Brands LLC |
| 18697398 | MNO NANOMATERIAL BASED INHIBITORS OF INFLAMMATION AND SARS-COV-2 VIRAL REPLICATION | Non-Final OA | NewSouth Innovations Pty Limited |
| 18697878 | COMPOSITIONS AND METHODS FOR LEVODOPA DELIVERY | Non-Final OA | NANOMERICS LTD. |
| 18697489 | DRESSING FOR TREATING HARD-TO-HEAL WOUNDS AND A PROCESS FOR THE MANUFACTURE THEREOF | Non-Final OA | Warszawski Uniwersytet Medyczny |
| 18697370 | ORAL LIQUID ENZALUTAMIDE COMPOSITIONS | Non-Final OA | FERRING B.V. |
| 18696785 | COMPOSITIONS OF DECIDUA TISSUE AND USES THEREOF | Non-Final OA | OSIRIS THERAPEUTICS, INC. |
| 17310241 | SUNSCREEN COMPOSITIONS | Non-Final OA | BEIERSDORF AG |
| 18587982 | RETINOL DERIVATIVE COMPOSITION AND USE THEREOF | Non-Final OA | DermaHealth Shanghai Biotechnology Co., Ltd. |
| 18682685 | LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF | Non-Final OA | ModernaTX, Inc. |
| 18682481 | DOSAGE FORM FOR IMPROVING PALATABILITY OF DRUG SUBSTANCE | Non-Final OA | ACER THERAPEUTICS, INC. |
| 18432125 | Implantable Device for Release of Glucagon-Like Peptide-1 Receptor Agonist | Non-Final OA | Celanese EVA Performance Polymers LLC |
| 18285918 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | Non-Final OA | Avantor Performance Materials, LLC |
| 17864120 | FLUID EXCHANGE APPARATUS FOR EXPANDABLE PORT DELIVERY SYSTEM AND METHODS OF USE | Non-Final OA | ForSight Vision4, Inc. |
| 18179863 | TINCTURE CONTAINING CANNABINOIDS, METHOD OF USING, AND METHOD OF MAKING THE SAME | Non-Final OA | Holistic Hemp Solutions, Inc. |
| 17792196 | AN ADHESIVE BODY DRESSING AND METHOD FOR MANUFACTURING AN ADHESIVE BODY DRESSING | Non-Final OA | DERMECO OY |
| 17617278 | BIOCIDAL COMPOSITE MATERIAL | Non-Final OA | PENNOG LIMITED |
| 17434200 | THERMALLY STABLE ANTIBACTERIAL QUATERNARY AMMONIUM NANOPARTICLES | Non-Final OA | NOBIO LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy